Agfa HealthCare announces today, that it has acquired the TIP Group, which is based in Graz, Austria. This merger of two healthcare pioneers will broaden Agfa HealthCare’s portfolio with specialized Business Intelligence and ERP solutions for hospitals.
Specialized tools for Business Intelligence
“The merger with the TIP Group will give us access to a specialist in hospital Business Intelligence, with solutions that will extend our global offering in a meaningful way,” says Winfried Post, CEO and General Manager, Agfa HealthCare GmbH. “Business Intelligence solutions are ever-more important for hospitals. The increasing cost pressures in healthcare will only be efficiently managed in the future using specialized tools. With this acquisition, we now have a solution that is tailored to the data integration and analysis needs of the hospital, allowing us to generate an even higher added value for healthcare facilities.”
Agfa HealthCare (agfahealthcare.com) and the TIP Group (tip-ag.com) both have long-standing experience in healthcare and in the optimization of processes. Combined with deep insight into hospital workflows, this will enable the advantages of a joint future will be realized quickly, and an extremely powerful team will emerge from the merger.
Extended portfolio of solutions
“The acquisition by Agfa HealthCare opens up new possibilities for our comprehensive product portfolio,” says Heimo Babcicky, chairman and founder of the TIP Group. “Agfa HealthCare is a strong and solid partner for us and for our customers, which enables us to jointly offer a larger portfolio. In this way, our solutions improve and our customers benefit from our cooperation.”
The new partners will begin working together immediately, to mutually make the change for a successful future.
Source: Agfa HealthCare
Johnson Matthey Plc (JM; London) announced that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
Lonza AG (Basel, Switzerland) announced it has signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, Calif. from Roche (Basel, Switzerland) for $1.2 billion. The acquisition will significantly increase Lonza’s large-scale biologics manufacturing capacity.
Roquette plans to acquire International Flavors & Fragrances (IFF) Pharma Solutions for an enterprise value of up to €2.85 billion (US$3.09 billion). With the acquisition set to close in the first half of 2025, the plant-based ingredient and pharmaceutical excipients supplier aims to reinforce its position in the pharmaceutical industry.